logo
Select company
Select metric
$ -131.32MEarning Before Interest & Taxes (EBIT)
VS
Market
8
Sector
16
Industry
22
History
83
$ 2.19Close
$ 0.67 - $ 3.46 52-Week Range
Ticker Information

Ticker

GOSS

Company Name

GOSSAMER BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GOSSAMER BIO INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GOSS - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -131.32M
3/31/2025$ -39.21M
12/31/2024$ -44.12M
9/30/2024$ -56.33M
6/30/2024$ -63.79M
3/31/2024$ -159.44M
12/31/2023$ -166.31M
9/30/2023$ -173.7M
6/30/2023$ -192.93M
3/31/2023$ -206.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GOSSAMER BIO INC's latest trailing twelve months (TTM) EBIT stands at $ -233.45M.
  • Over the past 5 years, GOSSAMER BIO INC's average EBIT has been $ -171.75M.
  • The median EBIT for GOSSAMER BIO INC during this period was $ -210.43M
  • GOSSAMER BIO INC reached its highest EBIT over the past 5 years at $ -39.21M.
  • The lowest EBIT recorded by GOSSAMER BIO INC in the same timeframe $ -233.45M

GOSSAMER BIO INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
XOMA : XOMA ROYALTY CORP $ -4.46MMGTX : MEIRAGTX HOLDINGS PLC $ -144.66MAUTL : AUTOLUS THERAPEUTICS PLC $ -240.51MALMS : ALUMIS INC $ -236.08MBCYC : BICYCLE THERAPEUTICS PLC $ -248.02MLXRX : LEXICON PHARMACEUTICALS INC $ -108.05MEDIT : EDITAS MEDICINE INC $ -242.16MFENC : FENNEC PHARMACEUTICALS INC $ -8.49MSCPH : SCPHARMACEUTICALS INC $ -85.59MEYPT : EYEPOINT PHARMACEUTICALS INC $ -175.18M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

GOSS - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -233.45M

Minimum

Sep 30, 2020

$ -39.21M

Maximum

Mar 31, 2025

$ -171.75M

Average

$ -210.43M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M